Optical coherence tomography assessment of acute thrombogenicity at bifurcation sites using different stenting techniques: A porcine arteriovenous shunt study

Catheter Cardiovasc Interv. 2022 Jun;99(7):1998-2005. doi: 10.1002/ccd.30187. Epub 2022 Apr 29.

Abstract

Objectives: We aimed to compare bare-metal stents (BMS), durable-polymer everolimus-eluting stents (DP-EES), and abluminal biodegradable-polymer sirolimus-eluting stents (ABP-SES) in the bifurcation model setup.

Background: The mechanism of thrombogenicity, which differs among second-generation stents implanted using double-kissing (DK) crush or culotte stenting techniques, remains unclear. We have shown previously that setting up a porcine arteriovenous shunt model is feasible and useful to assess thrombogenicity at vessel bifurcation points.

Methods: Six porcine shunt models were prepared for the comparison between DK crush and culotte stenting techniques using BMS, DP-EES, and ABP-SES. Intracoronary imaging with high-resolution optical coherence tomography (OCT) was performed to evaluate the thrombogenicity in different stent types in the bifurcation stenting model and was evaluated by a core lab.

Results: Culotte stenting demonstrated more thrombogenicity at the proximal main branch (MB) with DP-EES, side branch (SB) with BMS, and the bifurcation site irrespective of the stent type, while DK crush technique exhibited thrombogenicity only at SB with BMS and ABP-SES. OCT analysis revealed malapposition of DP-EES in the proximal MB with culotte stenting. Stent expansion was generally larger in ABP-SES than BMS and DP-EES.

Conclusions: The study provides hypothesis-generating findings in distinct thrombogenicity of bifurcation stenting with DP- or ABP-coated drug-eluting stents.

Keywords: imaging, optical coherence tomography; left main coronary disease; optical coherence tomography; stent thrombosis; stent, bare metal; stent, drug eluting.

MeSH terms

  • Animals
  • Everolimus
  • Humans
  • Polymers
  • Prosthesis Design
  • Sirolimus
  • Stents*
  • Swine
  • Tomography, Optical Coherence*
  • Treatment Outcome

Substances

  • Polymers
  • Everolimus
  • Sirolimus